The potential role of antivascular therapy in the adjuvant and neoadjuvant treatment of cancer

被引：51

作者：

Los, M ^{[1
]}

Voest, EE ^{[1
]}

机构：

[1] Univ Utrecht, Med Ctr, Dept Internal Med, Lab Med Oncol, NL-3508 GA Utrecht, Netherlands

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 01期

关键词：

D O I：

10.1053/sonc.2001.20752

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：93 / 105

页数：13

共 105 条

[1] Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].

Arap, W ;

Pasqualini, R ;

Ruoslahti, E .

SCIENCE, 1998, 279 (5349) :377-380

[2]

Bauer KS, 2000, J PHARMACOL EXP THER, V292, P31

[3]

Beinert T, 1999, Eur J Med Res, V4, P328

[4]

Bloemendal HJ, 1999, EUR J CLIN INVEST, V29, P802

[5] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].

Boehm, T ;

Folkman, J ;

Browder, T ;

OReilly, MS .

NATURE, 1997, 390 (6658) :404-407

[6] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].

BROOKS, PC ;

CLARK, RAF ;

CHERESH, DA .

SCIENCE, 1994, 264 (5158) :569-571

[7] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].

BROOKS, PC ;

MONTGOMERY, AMP ;

ROSENFELD, M ;

REISFELD, RA ;

HU, TH ;

KLIER, G ;

CHERESH, DA .

CELL, 1994, 79 (07) :1157-1164

[8] INHIBITION OF CELL MOTILITY BY INTERFERON [J].

BROUTYBOYE, D ;

ZETTER, BR .

SCIENCE, 1980, 208 (4443) :516-518

[9]

Cai T, 1999, LAB INVEST, V79, P1151

[10] PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS IN BLOOD AND TUMOR FLUIDS OF PATIENTS WITH OVARIAN-CANCER [J].

CASSLEN, B ;

BOSSMAR, T ;

LECANDER, I ;

ASTEDT, B .

EUROPEAN JOURNAL OF CANCER, 1994, 30A (09) :1302-1309

← 1 2 3 4 5 6 7 8 9 10 →